How does a clinician determine maintenance dosing using half-life?

• A. Use the drug's half-life to determine dosing intervals and steady-state time; adjust dosing to maintain target concentration.
• B. Increase dose until adverse effects appear.
• C. Administer a single large dose to reach target concentration quickly.
• D. Half-life does not affect dosing; fixed dosing is standard.

Answer: (A)

The main idea is that how fast a drug is eliminated, measured by its half-life, guides both how often you give maintenance doses and how long it takes to reach a steady-state concentration. Because half-life tells you how quickly the drug disappears from the body, you choose a dosing interval that keeps drug levels within the desired therapeutic range: too frequent dosing can cause buildup and higher peaks; too infrequent dosing can let levels fall below what's needed. The maintenance dose is then set to replace roughly what the body removes in each dosing interval, so the average concentration stays around the target level. In practice, reaching steady-state typically takes about 4–5 half-lives, which helps clinicians predict when the patient will achieve a stable level and adjust the dose accordingly to stay within the therapeutic window. The other ideas—giving a single large dose as a quick fix, increasing dose until adverse effects appear, or using fixed dosing without regard to half-life—don’t align with how maintenance dosing is intended to maintain consistent, safe drug exposure.